<?xml version="1.0" encoding="UTF-8" ?>
<Rows>
<Row>
  <RID>00003297</RID> <DATE_OF_BIRTH>1949</DATE_OF_BIRTH> <SEX>M</SEX> <AGE_DIAGNOSIS> 66.0</AGE_DIAGNOSIS> <AGE_OPERATION> 66.0</AGE_OPERATION> <AGE_CURRENT> 71.0</AGE_CURRENT>   <HEIGHT> 157.3</HEIGHT> <WEIGHT> 49.3</WEIGHT> <BMI> 20.0</BMI> <BSA> 1.46</BSA> <DIAGNOSIS_NAME>C1690.000.04</DIAGNOSIS_NAME> <DIAGNOSIS_DATE>2015-12-07</DIAGNOSIS_DATE> <DIAGNOSIS_DATE_1>2015-12-07</DIAGNOSIS_DATE_1> <DIAGNOSIS_DATE_2>2015-12-07</DIAGNOSIS_DATE_2> <DATE_PREOP_GASTROSCOPY>2015-12-07</DATE_PREOP_GASTROSCOPY> <RESULT_PREOP_GASTROSCOPY>[FINDING]
[EGD]

# EGD indication [ ]
①	증상(출혈 포함)에 대한 원인 규명
②	선별검사
③	추적감시검사
④	치료적 목적

Premedication(진경제[yes]:Algiron 5mg)주사 후 10% Lidocaine spray 인두마취시행함.
위내시경을 시행함.

식도 : 정상  

위 :  EGC IIc+III
1) Gross type :EGC IIc+III

2) Location of cancer : PW 
3) Size :  5x 3 cm  -&gt; indigo carmine apply 후 Bx.G1 
4) Upper margin of cancer : angle 하방  &gt;5 cm 
5) Lower margin of cancer : pyloric ring 상방 0.5 cm 
6) Depth of cancer : sm 으로 추정됨.

십이지장: 특이소견 없음.

생검용 포셉 사용함:

- no immediate complication 
- 검사 종료 후 통증 사정: 통증(무)
- 내시경소견과 조직검사시 부위는 PACS참조
</RESULT_PREOP_GASTROSCOPY> <NUMBER_OF_TUMRS> 1.0</NUMBER_OF_TUMRS> <TUMOR_SIZE>5.0</TUMOR_SIZE> <LOCATION_VERTICAL_GASTROSCOPY> 3.0</LOCATION_VERTICAL_GASTROSCOPY> <LOCATION_HORIZONTAL_GASTROSCOPY> 3.0</LOCATION_HORIZONTAL_GASTROSCOPY> <GROSS_TYPE_GASTROSCOPY> 4.0</GROSS_TYPE_GASTROSCOPY>       <ULCER_GASTROSCOPY> 0.0</ULCER_GASTROSCOPY> <CT_DATE>2015-12-08</CT_DATE> <CT_RESULT>[FINDING]
1.       T staging: T(2) 
-         Site: 2.8 cm sized wall thickening with central ulcer at LC side of antrum. 
-         Local invasion; -
-         Direct invasion to adjacent organ; -

2.       N staging: N(0 )
-         단경이 8mm 이상인 regional LN 수; None
- 

3.       M staging: M(0 )
-         distant metastasis; -
-         peritoneal carcinomatosis; -

4.       Lt gastric artery, splenic artery variation 여부: None

5.       Other findings 
- A 0.8cm sized GB stone. 
- A 0.5 cm sized calcification in R kidney lower pole. 
- A 1.3 cm sized cyst in S8.



[CONCLUSION]
Stomach cancer at LC side of antrum; T2N0 
A 0.8cm sized GB stone. 
A 0.5cm sized calyceal stone in R kidney lower pole.</CT_RESULT> <CT_TSTAGE1>20</CT_TSTAGE1>  <CT_NSTAGE1>00</CT_NSTAGE1>  <CT_MSTAGE1>0</CT_MSTAGE1>  <PETCT_DATE>2015-12-15</PETCT_DATE> <PETCT_RESULT>[FINDING]
PROCEDURE: 
검사 직전에 측정한 환자의 혈당치는 106 mg/dl, 신장 157 cm, 체중 51 kg이었고, F-18 FDG 5.9 mCi를 left hand에 정맥주사하고 1시간 후에 vertex에서 proximal thigh까지의 torso 영상을 얻음.

CLINICAL INFORMATION
1. Stomach cancer.
2. Bx: stomach, antrum, posterior wall (atypical glands, consistent c adenocarcinoma), 2015/12/7; antrum (tubular adenoma, MD), 2015/11/23, 외부.
3. Other Hx: (1)angina; (2)COPD; (3)BPH; (4)colonoscopic biopsy, rectum, AV10cm (tubular adenoma with low grade dysplasia), 2015/12/7.
4. Initial staging.

FINDINGS:
Stomach antrum에 focal FDG uptake이 있음(SUVmax 6.9).
GB stone이 있음. 

Right lower paratracheal region, paraaortic region, left peribronchial region에 focal FDG uptake들이 있음. 
Both lungs에 emphysema가 있음. 
다른 특이소견 없음.
[CONCLUSION]
1. Hypermetabolic malignant tumor in stomach antrum. 
2. GB stone. 
3. Reactive LNs in right lower paratracheal region, paraaortic region, and left peribronchial region. 
4. Emphysema in both lungs.</PETCT_RESULT> <OPERATION_DATE>2015-12-21</OPERATION_DATE> <OP_APPROACH> 99.0</OP_APPROACH> <OP_RADICALITY> 0.0</OP_RADICALITY> <OP_RESECTION_EXTENT> 1.0</OP_RESECTION_EXTENT> <OP_LYMPHNODE_DISSECTION> 1.0</OP_LYMPHNODE_DISSECTION> <OP_COMBINED_RESECTION> 99.0</OP_COMBINED_RESECTION> <OP_ANASTOMOSIS> 1.0</OP_ANASTOMOSIS> <ST_STAGE> 2.0</ST_STAGE> <SN_STAGE> 2.0</SN_STAGE> <SM_STAGE> 1.0</SM_STAGE> <s-H> 99.0</s-H> <s-P> 99.0</s-P> <ASCITES>No</ASCITES> <CYTOLOGY>No</CYTOLOGY> <OPERATION_TIME> 220.0</OPERATION_TIME> <BLOOD_LOSS>200</BLOOD_LOSS> <PATHOLOGY_REPORT_DATE>2015-12-21</PATHOLOGY_REPORT_DATE> <PATHOLOGY_NUMBER_OF_TUMOR> 1.0</PATHOLOGY_NUMBER_OF_TUMOR> <TUMOR_SIZE_LONG_DIAMETER> 3.0</TUMOR_SIZE_LONG_DIAMETER> <TUMOR_SIZE_MIN_DIAMETER> 1.6</TUMOR_SIZE_MIN_DIAMETER> <PATHOLOGY_LOCATION_VERTICAL> 3.0</PATHOLOGY_LOCATION_VERTICAL> <PATHOLOGY_LOCATION_HORIZONTAL> 3.0</PATHOLOGY_LOCATION_HORIZONTAL> <GROSS_TYPE_PATHOLOGY> 3.0</GROSS_TYPE_PATHOLOGY> <RESECTION_MARGIN_PROXIMAL> 9.6</RESECTION_MARGIN_PROXIMAL> <RESECTION_MARGIN_DISTAL> 0.7</RESECTION_MARGIN_DISTAL> <PATHOLOGY_DEPTH_OF_INVASION> 4.0</PATHOLOGY_DEPTH_OF_INVASION>  <PT_STAGE> 4.0</PT_STAGE> <PN_STAGE> 1.0</PN_STAGE> <PM_STAGE> 0.0</PM_STAGE> <METASTATIC_LYMPHNODE>0</METASTATIC_LYMPHNODE> <RETRIEVED_LYMPHNODE>15</RETRIEVED_LYMPHNODE> <LYMPHNODE_1_METASTASIS>0</LYMPHNODE_1_METASTASIS> <LYMPHNODE_1_RETRIEVED>1</LYMPHNODE_1_RETRIEVED>   <LYMPHNODE_3_METASTASIS>0</LYMPHNODE_3_METASTASIS> <LYMPHNODE_3_RETRIEVED>3</LYMPHNODE_3_RETRIEVED>     <LYMPHNODE_4SB_METASTASIS>0</LYMPHNODE_4SB_METASTASIS> <LYMPHNODE_4SB_RETRIEVED>0</LYMPHNODE_4SB_RETRIEVED> <LYMPHNODE_4D_METASTASIS>0</LYMPHNODE_4D_METASTASIS> <LYMPHNODE_4D_RETRIEVED>3</LYMPHNODE_4D_RETRIEVED> <LYMPHNODE_5_METASTASIS>0</LYMPHNODE_5_METASTASIS> <LYMPHNODE_5_RETRIEVED>1</LYMPHNODE_5_RETRIEVED> <LYMPHNODE_6_METASTASIS>0</LYMPHNODE_6_METASTASIS> <LYMPHNODE_6_RETRIEVED>1</LYMPHNODE_6_RETRIEVED> <LYMPHNODE_7_METASTASIS>0</LYMPHNODE_7_METASTASIS> <LYMPHNODE_7_RETRIEVED>1</LYMPHNODE_7_RETRIEVED>   <LYMPHNODE_8A_METASTASIS>0</LYMPHNODE_8A_METASTASIS> <LYMPHNODE_8A_RETRIEVED>1</LYMPHNODE_8A_RETRIEVED>   <LYMPHNODE_9_METASTASIS>0</LYMPHNODE_9_METASTASIS> <LYMPHNODE_9_RETRIEVED>3</LYMPHNODE_9_RETRIEVED>     <LYMPHNODE_11P_METASTASIS>0</LYMPHNODE_11P_METASTASIS> <LYMPHNODE_11P_RETRIEVED>1</LYMPHNODE_11P_RETRIEVED>                   <PATHOLOGY_DIFFERENTIATION>7</PATHOLOGY_DIFFERENTIATION> <LAUREN_CLASSIFICATION> 0.0</LAUREN_CLASSIFICATION> <LYMPHATIC_INVASION> 1.0</LYMPHATIC_INVASION> <VASCULAR_INVASION> 0.0</VASCULAR_INVASION> <NEURAL_INVASION> 0.0</NEURAL_INVASION>     <LAST_VISIT_DATE>2020-05-26</LAST_VISIT_DATE> <OVERALL_SURVIVAL_LAST_VISIT> 1618.0</OVERALL_SURVIVAL_LAST_VISIT> </Row>
</Rows>